By end user, the market is segmented into pharmaceutical and biotechnology companies,
contract research organizations, academic research institutes, and other end users. Other end
user segment primarily includes cell banks, small cell culture laboratories and consultants,
microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities,
toxicology laboratories, and media/sera manufacturers.
The product segments included in the report are kits and reagents, services, and viral inactivation
systems and accessories.
Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new
biologics products launched will be the two most important growth drivers for this market in the
forecasted period (2016-2021). For instance, the number of new biologics products launched
annually witnessed a strong upward trend between 2003 and 2013. The number of new products
launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by
155%, from 355 treatments in 2001 to 907 in 2012. A strong pharmaceutical product pipeline will
aid the growth of the pharmaceutical and biotechnology industry, which is an important end user
of viral inactivation products.
Ask For Discount: https://www.marketsandmarkets.com/discountreports.asp?id=121427017
The geographic segments included in this report are Asia, Europe, North America, and the Rest
of the World (RoW). The North America segment is further divided into Canada and the U.S. Asia
segment is further divided into China, Japan, India, and Rest of Asia.
Major players in the Viral Inactivation Market include Clean Cells (France), Charles River
Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany),
Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A.
(Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi
PharmaTech (Cayman) Inc. (China).
Request Bundle of Adjacent Research Report:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=121427017
2